Chemotherapy for Bone Sarcomas in Adults: The MD Anderson Experience Other CDK4 inhibitors are in clinical trials, including LEE001 and LY2835219. These agents exhibit a somewhat different toxicity ...
Please provide your email address to receive an email when new articles are posted on . A 60-year-old man presented with right thigh pain for the past 3 months. He also noted a mass progressively ...
Q: Which doctor should I consult if I have a lump with increasing size and pain? A: If someone is having lump of increasing size and pain,one should first visit a general practitioner who will refer ...
Now that you've gotten your diagnosis of liposarcoma, a type of cancer that starts in fat cells, it's time to learn how to best manage your doctor's visits and deal with treatment side effects. It's ...
Liposarcomas are a rare type of malignancy with a very heterogeneous morphological appearance and clinical course. The therapeutic approach is based on histopathological classification and is ...
The approval of Halaven was based on an improvement in overall survival (OS) in a phase 3 study. The FDA has approved Halaven (eribulin mesylate) as a treatment for patients with advanced or ...
De-intensification of preoperative radiation therapy is both effective and oncologically safe in patients with myxoid liposarcoma, an extremely rare type of soft tissue sarcoma (STS). The lower doses ...
The metastatic incidence of retroperitoneal dedifferentiated liposarcoma is comparatively lower than other pleomorphic sarcomas, varying widely from 1 to 18%. Low-grade dedifferentiation resembling ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- ...
A healthy, 53-year-old man presented with a small, soft, nontender mass of his right upper arm that progressively grew larger and more firm during the 6 weeks before evaluation (Figure 1). The ...
Please provide your email address to receive an email when new articles are posted on . Milademetan failed to significantly extend PFS among patients with dedifferentiated liposarcoma, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results